Cell (1)
Launched (1)
Human (1)
- (1)
- (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
CHEK-ATP205 | HEK293 | HEK293/Human GLP-1R&GIPR Stable Cell Line |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Dyne-101 | Dyne101 | Phase 2 Clinical | Myotonic Dystrophy; Muscular Atrophy | Details | |
| ARO-DM1 | ARO-DM1 | Phase 2 Clinical | Arrowhead Pharmaceuticals Inc | Myotonic Dystrophy | Details |

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8



